Orrù A. · Marchese G. · Ruiu S.

Author affiliations

Institute of Translational Pharmacology, National Research Council of Italy, Parco Scientifico e Tecnologico della Sardegna, Pula, Italy

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent via DeepDyve Unlimited fulltext viewing of this article Organize, annotate and mark up articles Printing and downloading restrictions apply

Start free trial

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: June 16, 2022
Accepted: October 17, 2022
Published online: February 08, 2023

Number of Print Pages: 7
Number of Figures: 3
Number of Tables: 0

ISSN: 0031-7012 (Print)
eISSN: 1423-0313 (Online)

For additional information: https://www.karger.com/PHA

Abstract

The anti-inflammatory properties of the medicinal plant Withania somnifera (L.) Dunal (WS) are generally related to withanolides; consistently, several strategies are under investigation to increase the concentration of these compounds in WS extracts. However, a potential toxicity of withanolides has been highlighted, thus questioning the safety of such preparations. At variance, the relative contribution of alkaloids is underrated, in spite of preliminary evidence underlining a possible pharmacological relevance. Starting from these considerations, the efficacy/safety profile of WS root extract (WSE) was compared with those of WS extracts which are enriched in alkaloids (WSA) and withanolides (WSW), respectively. MTT assay was used to evaluate cell viability. The anti-inflammatory activities of the different extracts were estimated throughout the assessment of the inhibition of lipopolysaccharide (LPS)-activated release of nitric oxide (NO) and the upregulation of iNOS and COX-2 protein in RAW 264.7 cells. Both WSA and WSW were able to reduce LPS-mediated effects in RAW 264.7 cells, suggesting that alkaloids and withanolides may contribute to the anti-inflammatory activity of WSE. A significant higher anti-inflammatory activity and a lower toxicity were observed when WSA was compared to WSW. The present results highlighted that the contribution of alkaloids to WS pharmacological effects should not be neglected. Particularly, these compounds may concur to reach a more advantageous efficacy/safety profile when WS is used for anti-inflammatory purposes.

© 2023 S. Karger AG, Basel

References Paul S, Chakraborty S, Anand U, Dey S, Nandy S, Ghorai M, et al. Withania somnifera (L.) Dunal (Ashwagandha): a comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects. Biomed Pharmacother. 2021;143:112175. Gupta M, Kaur G. Withania somnifera as a potential anxiolytic and anti-inflammatory candidate against systemic lipopolysaccharide-induced neuroinflammation. Neuromolecular Med. 2018;20(3):343–62. Orrù A, Marchese G, Casu G, Casu MA, Kasture S, Cottiglia F, et al. Withania somnifera root extract prolongs analgesia and suppresses hyperalgesia in mice treated with morphine. Phytomedicine. 2014;21(5):745–52. Orrù A, Casu MA, Tambaro S, Marchese G, Casu G, Ruiu S. Withania somnifera (L.) Dunal root extract alleviates formalin-induced nociception in mice: involvement of the opioidergic system. Behav Pharmacol. 2016;27(1):57–68. Kumar V, Dey A, Hadimani MB. Marcović T, Emerald M. Chemistry and pharmacology of Withania somnifera: an update. Cellmed. 2015;5:1–13. White PT, Subramanian C, Motiwala HF, Cohen MS. Natural withanolides in the treatment of chronic diseases. Adv Exp Med Biol. 2016;928:329–73. Sultana T, Okla MK, Ahmed M, Akhtar N, Al-Hashimi A, Abdelgawad H, et al. Withaferin A: from ancient remedy to potential drug candidate. Molecules. 2021;26(24):7696. Kaur K, Dolker D, Behera S, Pati PK. Critical factors influencing in vitro propagation and modulation of important secondary metabolites in Withania somnifera (L.) dunal. Plant Cell Tissue Organ Cult. 2022;149(1–2):41–60. Namdeo AG, Ingawale DK. Ashwagandha: advances in plant biotechnological approaches for propagation and production of bioactive compounds. J Ethnopharmacol. 2021;271:113709. Von Bieberstein P, Xu YM, Gunatilaka AL, Gruener R. Biomass production and withaferin A synthesis by Withania somnifera grownin aeroponics and hydroponics. Hortscience. 2014;49(12):1506–9. Chen LX, He H, Qiu F. Natural withanolides: an overview. Nat Prod Rep. 2011;28(4):705–40. Pretorius E, Oberholzer HM, Becker PJ. Comparing the cytotoxic potential of Withania somnifera water and methanol extracts. Afr J Tradit Complement Altern Med. 2009;6(3):275–80. Saleem S, Muhammad G, Hussain MA, Altaf M, Bukhari SNA. Withania somnifera L.: insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective. Iran J Basic Med Sci. 2020;23(12):1501–26. Caputi FF, Acquas E, Kasture S, Ruiu S, Candeletti S, Romualdi P. The standardized Withania somnifera Dunal root extract alters basal and morphine-induced opioid receptor gene expression changes in neuroblastoma cells. BMC Complement Altern Med. 2018;18:9–10. Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakkara AB, Sung B, et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol. 2007;7(3):344–51. Logie E, Vanden Berghe W. Tackling chronic inflammation with withanolide phytochemicals: a withaferin A. Perspective. Antioxidants. 2020;9(11):1107. Eze FI, Uzor PF, Ikechukwu P, Obi BC, Osadebe PO. In vitro and in vivo models for anti-inflammation: an evaluative review. INNOSC Theranostics Pharmacol Sci. 2019;2:3–15. Iuvone T, Esposito G, Capasso F, Izzo AA. Induction of nitric oxide synthase expression by Withania somnifera in macrophages. Life Sci. 2003;72(14):1617–25. Mazzio EA, Li N, Bauer D, Mendonca P, Taka E, Darb M, et al. Natural product HTP screening for antibacterial (E.coli 0157:H7) and anti-inflammatory agents in (LPS from E. coli O111:B4) activated macrophages and microglial cells; focus on sepsis. BMC Complement Altern Med. 2016;16(1):467–75. Kim J, Kim H, Choi H, Jo A, Kang H, Yun H, et al. Anti-inflammatory effects of a stauntonia hexaphylla fruit extract in lipopolysaccharide-activated RAW-264.7 macrophages and rats by carrageenan-induced hind paw swelling. Nutrients. 2018;10:110–2. Le HTT, Cho YC, Cho S. Methanol extract of Guettarda speciosa Linn. inhibits the production of inflammatory mediators through the inactivation of Syk and JNK in macrophages. Int J Mol Med. 2018;41(3):1783–91. Kim MJ, Kim JG, Sydara KM, Lee SW, Jung SK. Croton hirtus L’hér extract prevents inflammation in RAW264.7 macrophages via inhibition of NF-κB signaling pathway. J Microbiol Biotechnol. 2020;30(4):490–6. Jeong YE, Lee MY. Anti-inflammatory activity of Populus deltoides leaf extract via modulating NF-κB and p38/JNK pathways. Int J Mol Sci. 2018;19(12):3746. Turrini E, Calcabrini C, Sestili P, Catanzaro E, de Gianni E, Diaz AR, et al. Withania somnifera induces cytotoxic and cytostatic effects on human T leukemia cells. Toxins. 2016;8(5):147–58. Philips CA, Ahamed R, Rajesh S, George T, Mohanan M, Augustine P. Comprehensive review of hepatotoxicity associated with traditional Indian Ayurvedic herbs. World J Hepatol. 2020;12(9):574–95. Siddiqui S, Ahmed N, Goswami M, Chakrabarty A, Chowdhury G. DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of Withania somnifera (Ashwagandha). Curr Res Toxicol. 2021;2:72–81. Devkar ST, Kandhare AD, Zanwar AA, Jagtap SD, Katyare SS, Bodhankar SL, et al. Hepatoprotective effect of withanolide-rich fraction in acetaminophen-intoxicated rat: decisive role of TNF-α, IL-1β, COX-II and Inos. Pharm Biol. 2016;54(11):2394–403. Patel SB, Rao NJ, Hingorani LL. Safety assessment of Withania somnifera extract standardized for Withaferin A: acute and sub-acute toxicity study. J Ayurveda Integr Med. 2016;7(1):30–7. Kashyap VK, Peasah-Darkwah G, Dhasmana A, Jaggi M, Yallapu MM, Chauhan SC. Withania somnifera: progress towards a pharmaceutical agent for immunomodulation and cancer therapeutics. Pharmaceutics. 2022;14(3):611. Maccioni R, Serra M, Marongiu J, Cottiglia F, Maccioni E, Bassareo V, et al. 1,3 Effects of docosanyl ferulate, a constituent of Withania somnifera, on ethanol- and morphine-elicited conditioned place preference and ERK phosphorylation in the accumbens shell of CD1 mice. Psychopharmacology. 2022;239(3):795–806. Sonar VP, Fois B, Distinto S, Maccioni E, Meleddu R, Cottiglia F, et al. Ferulic acid esters and withanolides: in search of Withania somnifera GABA A receptor modulators. J Nat Prod. 2019;82(5):1250–7. Article / Publication Details

First-Page Preview

Received: June 16, 2022
Accepted: October 17, 2022
Published online: February 08, 2023

Number of Print Pages: 7
Number of Figures: 3
Number of Tables: 0

ISSN: 0031-7012 (Print)
eISSN: 1423-0313 (Online)

For additional information: https://www.karger.com/PHA

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.